Works matching DE "ROSIGLITAZONE"

Results: 689

Improvement of Insulin Sensitivity by a Novel Drug Candidate, BGP-15, in Different Animal Studies.

Published in:

Metabolic Syndrome & Related Disorders, 2014, v. 12, n. 2, p. 125, doi. 10.1089/met.2013.0098

By:

Literáti-Nagy, Botond;
Tory, Kálmán;
Peitl, Barna;
Bajza, Ágnes;
Korányi, László;
Literáti-Nagy, Zsuzsanna;
Hooper, Philip L.;
Vígh, László;
Szilvássy, Zoltán

Publication type:

Article

Portable Dual‐Modular Immunosensor Constructed from Bimetallic Metal–Organic Framework Heterostructure Grafted with Enzyme‐Mimicking Label for Rosiglitazone Detection.

Published in:

Advanced Functional Materials, 2022, v. 32, n. 30, p. 1, doi. 10.1002/adfm.202203244

By:

Qileng, Aori;
Liu, Weipeng;
Sun, Ziqi;
Zhou, Weichi;
Fang, Yueping;
Lei, Hongtao;
Liu, Yingju;
Zhang, Shengsen

Publication type:

Article

Rosiglitazone Inhibits Bone Regeneration and Causes Significant Accumulation of Fat at Sites of New Bone Formation.

Published in:

Calcified Tissue International, 2012, v. 91, n. 2, p. 139, doi. 10.1007/s00223-012-9623-4

By:

Liu, Lichu;
Aronson, James;
Huang, Shilong;
Lu, Yalin;
Czernik, Piotr;
Rahman, Sima;
Kolli, Vipula;
Suva, Larry;
Lecka-Czernik, Beata

Publication type:

Article

The Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Increases Bone Resorption in Women with Type 2 Diabetes: A Randomized, Controlled Trial.

Published in:

Calcified Tissue International, 2010, v. 86, n. 5, p. 343, doi. 10.1007/s00223-010-9352-5

By:

Gruntmanis, Ugis;
Fordan, Steve;
Ghayee, Hans K.;
Abdullah, Shuaib M.;
See, Raphael;
Ayers, Colby R.;
McGuire, Darren K.

Publication type:

Article

Thiazolidinediones improve flow-mediated dilation: a meta-analysis of randomized clinical trials.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 4, p. 385, doi. 10.1007/s00228-015-1999-4

By:

Stojanović, Marko;
Prostran, Milica;
Radenković, Miroslav

Publication type:

Article

Application of in vitro-in vivo extrapolation (IVIVE) and physiologically based pharmacokinetic (PBPK) modelling to investigate the impact of the CYP2C8 polymorphism on rosiglitazone exposure.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 6, p. 1311, doi. 10.1007/s00228-012-1467-3

By:

Yeo, Karen;
Kenny, Jane;
Rostami-Hodjegan, Amin

Publication type:

Article

Pharmacokinetic drug interaction between gemfibrozil and sitagliptin in healthy Indian male volunteers.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 709, doi. 10.1007/s00228-011-1177-2

By:

K. P., Arun;
Meda, Venkata;
Kucherlapati, V.;
Dubala, Anil;
M., Deepalakshmi;
P. R., Anand;
K., Elango;
B., Suresh

Publication type:

Article

A randomised controlled trial on melatonin and rosiglitazone for prevention of adhesion formation in a rat uterine horn model.

Published in:

Archives of Gynecology & Obstetrics, 2010, v. 282, n. 1, p. 55, doi. 10.1007/s00404-009-1240-8

By:

Aksakal, Orhan;
Yilmaz, Bulent;
Gungor, Tayfun;
Sirvan, Levent;
Sut, Necdet;
Inan, Ismet;
Kalyoncu, Senol;
Mollamahmutoglu, Leyla

Publication type:

Article

Seven days: 29 November-5 December 2013.

Published in:: Nature, 2013, v. 504, n. 7478, p. 12, doi. 10.1038/504012a
Publication type:: Article

Seven days: 7-13 June 2013.

Published in:: Nature, 2013, v. 498, n. 7453, p. 142, doi. 10.1038/498142a
Publication type:: Article

Pharmacological Characterization of YM543, a Newly Synthesized, Orally Active SGLT2 Selective Inhibitor.

Published in:

Endocrine Research, 2013, v. 38, n. 3, p. 168, doi. 10.3109/07435800.2012.746364

By:

Yokono, Masanori;
Tahara, Atsuo;
Kurosaki, Eiji;
Yamajuku, Daisuke;
Kihara, Rumi;
Imamura, Masakazu;
Tomiyama, Hiroshi;
Kobayashi, Yoshinori;
Noda, Atsushi;
Shibasaki, Masayuki

Publication type:

Article

Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology.

Published in:

Neuropsychopharmacology, 2010, v. 35, n. 7, p. 1593, doi. 10.1038/npp.2010.32

By:

Escribano, Luis;
Simón, Ana-María;
Gimeno, Esther;
Cuadrado-Tejedor, Mar;
de Maturana, Rakel López;
García-Osta, Ana;
Ricobaraza, Ana;
Pérez-Mediavilla, Alberto;
Río, Joaquín Del;
Frechilla, Diana

Publication type:

Article

Challenges and Opportunities for Biomarker Validation.

Published in:: Journal of Law, Medicine & Ethics, 2019, v. 47, n. 3, p. 357, doi. 10.1177/1073110519876162
Publication type:: Article

miRNA-9-5p 与NF-资B 信号通路在2 型糖尿病肾病发病中的作用机制.

Published in:

Progress in Modern Biomedicine, 2019, v. 19, n. 17, p. 3239, doi. 10.13241/j.cnki.pmb.2019.17.008

By:

陈洁;
罗敏虹;
陈兴强;
张萌;
符薇薇

Publication type:

Article

No causal effects between rosiglitazone and cardiovascular disease or risk factors: a Mendelian randomization study.

Published in:

European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 11, p. 5280

By:

LI, X.-M.;
WU, Z.-J.;
XU, Z.-L.;
LI, A.;
LIU, M.-Q.;
SONG, C.-G.;
WU, K.

Publication type:

Article

Rosiglitazone May Assist With Glycemic Control in the ICU.

Published in:

Journal of Intensive Care Medicine, 2010, v. 25, n. 2, p. 117, doi. 10.1177/0885066609355264

By:

Lissauer, Matthew;
Feild, Carinda;
Fasanmi, Foyin;
Johnson, Steven B.

Publication type:

Article

Rosiglitazone lowers resting and blood pressure response to exercise in men with type 2 diabetes: A 1‐year randomized study.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 7, p. 1740, doi. 10.1111/dom.13293

By:

Piché, Marie‐eve;
Laberge, Anne‐sophie;
Brassard, Patrice;
Arsenault, Benoit J.;
Bertrand, Olivier F.;
Després, Jean‐pierre;
Costerousse, Olivier;
Poirier, Paul

Publication type:

Article

Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial.

Published in:

Diabetes, Obesity & Metabolism, 2015, v. 17, n. 10, p. 949, doi. 10.1111/dom.12487

By:

Florez, H.;
Reaven, P. D.;
Bahn, G.;
Moritz, T.;
Warren, S.;
Marks, J.;
Reda, D.;
Duckworth, W.;
Abraira, C.;
Hayward, R.;
Emanuele, N.

Publication type:

Article

Glucagon-like peptide 1 receptor agonists and cardiovascular risk in type 2 diabetes: a clinical perspective.

Published in:

Diabetes, Obesity & Metabolism, 2015, v. 17, n. 4, p. 335, doi. 10.1111/dom.12380

By:

Fisher, M.

Publication type:

Article

APOE* 3Leiden. CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome.

Published in:

Diabetes, Obesity & Metabolism, 2014, v. 16, n. 6, p. 537, doi. 10.1111/dom.12252

By:

van den Hoek, A. M.;
van der Hoorn, J. W. A.;
Maas, A. C.;
van den Hoogen, R. M.;
van Nieuwkoop, A.;
Droog, S.;
Offerman, E. H.;
Pieterman, E. J.;
Havekes, L. M.;
Princen, H. M. G.

Publication type:

Article

Observational follow-up of the PROactive study: a 6-year update.

Published in:

Diabetes, Obesity & Metabolism, 2014, v. 16, n. 1, p. 63, doi. 10.1111/dom.12180

By:

Erdmann, E.;
Song, E.;
Spanheimer, R.;
van Troostenburg de Bruyn, A.‐R.;
Perez, A.

Publication type:

Article

Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?

Published in:

Diabetes, Obesity & Metabolism, 2013, v. 15, n. 11, p. 967, doi. 10.1111/dom.12101

By:

Consoli, A.;
Formoso, G.

Publication type:

Article

News and Views.

Published in:

Diabetes, Obesity & Metabolism, 2012, v. 14, n. 7, p. 673, doi. 10.1111/j.1463-1326.2012.01621.x

By:

Idris, Iskandar

Publication type:

Article

The design of the liraglutide clinical trial programme.

Published in:

Diabetes, Obesity & Metabolism, 2012, v. 14, p. 4, doi. 10.1111/j.1463-1326.2012.01573.x

By:

Nauck, M. A.

Publication type:

Article

Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study.

Published in:

Diabetes, Obesity & Metabolism, 2012, v. 14, n. 2, p. 181, doi. 10.1111/j.1463-1326.2011.01510.x

By:

Lazich, I.;
Sarafidis, P.;
de Guzman, E.;
Patel, A.;
Oliva, R.;
Bakris, G.

Publication type:

Article

A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-na ïve type 2 diabetes mellitus patients

Published in:

Diabetes, Obesity & Metabolism, 2011, v. 13, n. 11, p. 1036, doi. 10.1111/j.1463-1326.2011.01461.x

By:

Borges, J. L. C.;
Bilezikian, J. P.;
Jones-Leone, A. R.;
Acusta, A. P.;
Ambery, P. D.;
Nino, A. J.;
Grosse, M.;
Fitzpatrick, L. A.;
Cobitz, A. R.

Publication type:

Article

Cardiovascular risk and thiazolidinediones-what do meta-analyses really tell us?

Published in:

Diabetes, Obesity & Metabolism, 2010, v. 12, n. 12, p. 1023, doi. 10.1111/j.1463-1326.2010.01262.x

By:

Schernthaner, G.;
Chilton, R. J.

Publication type:

Article

News and Views.

Published in:

Diabetes, Obesity & Metabolism, 2010, v. 12, n. 11, p. 1019, doi. 10.1111/j.1463-1326.2010.01310.x

By:

Idris, Iskandar

Publication type:

Article

Effects of physical exercise versus rosiglitazone on endothelial function in coronary artery disease patients with prediabetes.

Published in:

Diabetes, Obesity & Metabolism, 2010, v. 12, n. 9, p. 825, doi. 10.1111/j.1463-1326.2010.01234.x

By:

Desch, S.;
Sonnabend, M.;
Niebauer, J.;
Sixt, S.;
Sareban, M.;
Eitel, I.;
de Waha, S.;
Thiele, H.;
Blüher, M.;
Schuler, G.

Publication type:

Article

Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2010, v. 12, n. 9, p. 806, doi. 10.1111/j.1463-1326.2010.01237.x

By:

Rabøl, R.;
Boushel, R.;
Almdal, T.;
Hansen, C. N.;
Ploug, T.;
Haugaard, S. B.;
Prats, C.;
Madsbad, S.;
Dela, F.

Publication type:

Article

Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2010, v. 12, n. 8, p. 716, doi. 10.1111/j.1463-1326.2010.01225.x

By:

Aubert, R. E.;
Herrera, V.;
Chen, W.;
Haffner, S. M.;
Pendergrass, M.

Publication type:

Article

Selective effects of PPARγ agonists and antagonists on human pre-adipocyte differentiation.

Published in:

Diabetes, Obesity & Metabolism, 2010, v. 12, n. 3, p. 195, doi. 10.1111/j.1463-1326.2009.01149.x

By:

Leyvraz, C.;
Suter, M.;
Verdumo, C.;
Calmes, J.-M.;
Paroz, A.;
Darimont, C.;
Gaillard, R. C.;
Pralong, F. P.;
Giusti, V.

Publication type:

Article

Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2009, v. 11, n. 12, p. 1091, doi. 10.1111/j.1463-1326.2009.01087.x

By:

Derosa, G.;
Tinelli, C.;
Maffioli, P.

Publication type:

Article

FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF MATRIX TYPE TRANSDERMAL PATCHES OF ROSIGLITAZONE MALEATE.

Published in:

International Journal of Pharmaceutical, Chemical & Biological Sciences, 2016, v. 6, n. 2, p. 182

By:

Naik, V. Vasu;
Markonda, CH. Bala;
Rao, A. Anka;
Prasuli, M.

Publication type:

Article

FORMULATION AND EVALUATION OF FLOATING MICROSPHERES OF ROSIGLITAZONE.

Published in:

International Journal of Pharmaceutical, Chemical & Biological Sciences, 2015, v. 5, n. 4, p. 907

By:

Ramu, S.;
Suresh, P.;
Rao, D. Srinivasa;
Ramakrishna, G.

Publication type:

Article

Role of peroxisome proliferator–activated receptor-gamma activation on visfatin, advanced glycation end products, and renal oxidative stress in obesity-induced type 2 diabetes mellitus.

Published in:

Human & Experimental Toxicology, 2018, v. 37, n. 11, p. 1187, doi. 10.1177/0960327118757588

By:

Tabassum, A.;
Mahboob, T.

Publication type:

Article

Effects of prenatal PPAR-γ agonist rosiglitazone exposure on rat hippocampus development in a timedependent manner: A stereological and histopathological study.

Published in:

Human & Experimental Toxicology, 2018, v. 37, n. 8, p. 827, doi. 10.1177/0960327117730883

By:

Sağır, D.;
Eren, B.;
Yılmaz, B. D.;
Eren, Z.;
Keleş, O. N.;
Gökçe, A. B.

Publication type:

Article

A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US.

Published in:

Current Medical Research & Opinion, 2009, v. 25, n. 6, p. 1343, doi. 10.1185/03007990902870084

By:

Meaghan St. Charles;
Michael E. Minshall;
Bhavik J. Pandya;
Robert W. Baran;
Sandra L. Tunis

Publication type:

Article

In vitro and in vivo assessment of the effect of dalcetrapib on a panel of CYP substrates.

Published in:

Current Medical Research & Opinion, 2009, v. 25, n. 4, p. 891, doi. 10.1185/03007990902790928

By:

Derks, Michael;
Fowler, Stephen;
Kuhlmann, Olaf

Publication type:

Article

After Avandia.

Published in:

Texas Heart Institute Journal, 2012, v. 39, n. 2, p. 174

By:

Khalaf, Khaled I.;
Taegtmeyer, Heinrich

Publication type:

Article

Short-Term Therapy with Rosiglitazone, a PPAR-γ Agonist, Improves Metabolic Profile and Vascular Function in Nonobese Lean Wistar Rats.

Published in:

ISRN Pharmacology, 2012, p. 1, doi. 10.5402/2012/130347

By:

Naderali, Mohammad M.;
Itua, Imose;
Abubakari, Abdul-Razak;
Naderali, Ebrahim K.

Publication type:

Article

Thiazolidinediones: Understanding their role in diabetes management.

Published in:

African Journal of Diabetes Medicine, 2024, v. 32, n. 3, p. 9, doi. 10.54931/AJDM-32.3.4

By:

Rossi, Elisa

Publication type:

Article

DOSE RELATED STUDY IN NORMAL MICE AND ANTIDIABETIC EFFECT OF NATURAL EXTRACTS IN STREPTOZOTOCIN INDUCED DIABETIC MICE.

Published in:

International Journal of Pharmacology & Biological Sciences, 2011, v. 5, n. 3, p. 7

By:

Sengupta, Rupali;
Sawant, Chhaya S.;
Karmarkar, S. M.;
Bhagwat, A. M.

Publication type:

Article

The PPAR? Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects.

Published in:

Pulmonary Medicine, 2012, p. 1, doi. 10.1155/2012/545172

By:

Bogatkevich, Galina S.;
Highland, Kristin B.;
Akter, Tanjina;
Silver, Richard M.

Publication type:

Article

Effects of rosiglitazone pretreatment on blood glucose, lipid levels, urea, and microalbuminuria in rats undergoing 70% pancreatectomy.

Published in:

Open Access Surgery, 2013, v. 6, p. 1, doi. 10.2147/OAS.S39364

By:

Zafe Acar, Hasan;
Okan Senel, Oytun;
Bukan, Neslihan;
Yurekli, Banu;
Ebru Salman, A.;
Yetisir, Fahri

Publication type:

Article

Preparation and characterization of superporous hydrogels as gastroretentive drug delivery system for rosiglitazone maleate.

Published in:

DARU: Journal of Pharmaceutical Sciences, 2010, v. 18, n. 3, p. 200

By:

Vishal, Gupta N.;
Shivakumar, H. G.

Publication type:

Article

Behind the rosiglitazone controversy.

Published in:

Expert Review of Clinical Pharmacology, 2010, v. 3, n. 6, p. 723, doi. 10.1586/ecp.10.126

By:

Cheung, Bernard M. Y.

Publication type:

Article

Cardiovascular Safety of New Drugs for Diabetes: Getting the Balance Right?

Published in:

Pharmaceutical Medicine, 2014, v. 28, n. 3, p. 109, doi. 10.1007/s40290-014-0053-7

By:

Krentz, Andrew;
Hompesch, Marcus

Publication type:

Article

The Pharmaceutical Medicine Year that Was.

Published in:

2010

By:

Fox, Anthony W.

Publication type:

Opinion

Rosiglitazone use and associated adverse event rates in Canada between 2004 and 2010.

Published in:

BMC Research Notes, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-0500-6-82

By:

Rawson, Nigel S. B.;
Terres, Jorge A. Ross

Publication type:

Article